Laser Success Measured at time of procedure [clinicaltrials_resource:00036588154d544ef353f74477e61e12]
The primary efficacy endpoint is laser success, defined as achieving >/= 20% average reduction in the percent (%) diameter stenosis, post-laser and prior to adjunctive therapy, based on angiographic core laboratory assessment.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Laser Success Measured at time of procedure [clinicaltrials_resource:00036588154d544ef353f74477e61e12]
The primary efficacy endpoint is laser success, defined as achieving >/= 20% average reduction in the percent (%) diameter stenosis, post-laser and prior to adjunctive therapy, based on angiographic core laboratory assessment.
Bio2RDF identifier
00036588154d544ef353f74477e61e12
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:00036588154d544ef353f74477e61e12
measure [clinicaltrials_vocabulary:measure]
Laser Success
time frame [clinicaltrials_vocabulary:time-frame]
Measured at time of procedure
description
The primary efficacy endpoint ...... ic core laboratory assessment.
identifier
clinicaltrials_resource:00036588154d544ef353f74477e61e12
title
Laser Success Measured at time of procedure
@en
type
label
Laser Success Measured at time ...... 36588154d544ef353f74477e61e12]
@en